Corcept Therapeutics, Inc. (CORT) Misses Q1 Loss views by 2c/Share
Get Alerts CORT Hot Sheet
Price: $22.21 -1.2%
Revenue Growth %: +33.2%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +33.2%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q1 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- AptarGroup (ATR) Tops Q1 EPS by 11c
- COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!